Integra LifeSciences Announces Participation in Upcoming Investor Conferences
Integra LifeSciences Holdings Corporation (NASDAQ: IART) announced its participation in two upcoming investor conferences.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Integra LifeSciences Holdings Corporation (NASDAQ: IART) announced its participation in two upcoming investor conferences. CEO Jan De Witte will present at the Wells Fargo 2022 Healthcare Conference in Boston on September 7, 2022, at 8:35 am ET. CFO Carrie Anderson will speak at the Morgan Stanley Annual Global Healthcare Conference in New York on September 12, 2022, at 11:05 am ET. Interested parties can find webcast information on the Company’s website.
Details
News Market Reaction – IART
The recorded move for IART in the trading session of this news was -2.21%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
PRINCETON, N.J., Aug. 23, 2022 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, announced today that it is participating in the following investor conferences:
- On September 7, 2022, Jan De Witte, chief executive officer will present at the Wells Fargo 2022 Healthcare Conference in Boston, MA at 8:35am ET.
- On September 12, 2022, Carrie Anderson, executive vice president and chief financial officer will present at the Morgan Stanley Annual Global Healthcare Conference in New York, NY at 11:05am ET.
Webcast information can be found on the Company’s website at Investor Relations.
About Integra LifeSciences
Integra LifeSciences is a global leader in regenerative tissue technologies and neurosurgical solutions dedicated to limiting uncertainty for clinicians so they can focus on providing the best patient care. Integra offers a comprehensive portfolio of high quality, leadership brands that include AmnioExcel®, Aurora®, Bactiseal®, BioD™, CerebroFlo®, CereLink® Certas® Plus, Codman®, CUSA®, Cytal®, DuraGen®, DuraSeal®, Gentrix®, ICP Express®, Integra®, Licox® , MAYFIELD®, MediHoney®, MicroFrance®, MicroMatrix®, NeuraGen® , NeuraWrap™ , PriMatrix®, SurgiMend®, TCC-EZ® and VersaTru®. For the latest news and information about Integra and its products, please visit www.integralife.com.
Investor Relations:
Chris Ward
(609) 772-7736
chris.ward@integralife.com
Media Contact:
Laurene Isip
(609) 208-8121
laurene.isip@integralife.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.